Current trends of targeted therapy for oral squamous cell carcinoma Hongjiao LiYao ZhangDeqin Yang Review – Cancer Research 02 May 2022 Pages: 2169 - 2186
Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysis Roberto FalzChristian BischoffInes Gockel Review – Cancer Research Open access 13 June 2022 Pages: 2187 - 2213
Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression Rui LiuYachun JiaAili He Review – Cancer Research 28 June 2022 Pages: 2215 - 2230
Lymphovascular and perineural invasion are risk factors for inguinal lymph node metastases in men with T1G2 penile cancer Christian D. FankhauserHielke M. de VriesVijay Sangar Original Article – Cancer Research 12 April 2022 Pages: 2231 - 2234
Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis Sarah KriegChristoph RoderburgAndreas Krieg Original Article – Cancer Research Open access 15 April 2022 Pages: 2235 - 2246
Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer Xing TangHaolin HuangXiaopan Xu Original Article – Cancer Research 17 April 2022 Pages: 2247 - 2260
CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer Hongjia ZhuXiaoyan FangLei Yu Original Article – Cancer Research 21 April 2022 Pages: 2261 - 2274
R132H IDH1 sensitizes glioma to the antiproliferative and cytotoxic effects of BET inhibition Thomas K. SearsKevin D. Woolard Original Article – Cancer Research Open access 25 April 2022 Pages: 2275 - 2285
Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma Alexander DamanakisPatrick Sven PlumAlexander Quaas Original Article – Cancer Research Open access 27 April 2022 Pages: 2287 - 2293
Inflammation suppresses DLG2 expression decreasing inflammasome formation Simon KeaneMatthew HerringKatarina Ejeskär Original Article – Cancer Research Open access 02 May 2022 Pages: 2295 - 2311
Single-cell transcriptome highlights a multilayer regulatory network on an invasive trajectory within colorectal cancer progression Tong ZhouChunhua Li Original Article – Cancer Research 06 May 2022 Pages: 2313 - 2322
Fragmentation of care and colorectal cancer survival in South Korea: comparisons according to treatment at multiple hospitals Dong-Woo ChoiSeungju KimKyu-Tae Han Original Article – Cancer Research 06 May 2022 Pages: 2323 - 2333
The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy Man Yi LiLe MiZhi Long Chen Original Article – Cancer Research 06 May 2022 Pages: 2335 - 2346
Liquid biopsy: early and accurate diagnosis of brain tumor Zhenjie YiChunrun QuZhixiong Liu Review – Clinical Oncology 22 April 2022 Pages: 2347 - 2373
Liposomal formulations for lung cancer treatment in the last two decades: a systematic review Filipa CanãoHelena FerreiraNuno M. Neves Review – Clinical Oncology 04 June 2022 Pages: 2375 - 2386
Bidirectional effects of intestinal microbiota and antibiotics: a new strategy for colorectal cancer treatment and prevention Wenjie ZhangJie ZhangDong Tang Review – Clinical Oncology 04 June 2022 Pages: 2387 - 2404
MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety So Jung LeeMyungsoo KimHye Jin Kang Original Article – Clinical Oncology 06 September 2021 Pages: 2405 - 2414
Predictors for thromboembolism in patients with cholangiocarcinoma Christian PfrepperMaren KnödlerFlorian Lordick Original Article – Clinical Oncology Open access 09 September 2021 Pages: 2415 - 2426
The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors Hana KimSoomin AhnSeung Tae Kim Original Article – Clinical Oncology Open access 12 September 2021 Pages: 2427 - 2435
Early discontinuation of induction therapy in chemoimmunotherapy as an effective alternative to the standard regimen in patients with non-small cell lung cancer: a retrospective study Kenji MorimotoJunji UchinoKoichi Takayama Original Article – Clinical Oncology 12 September 2021 Pages: 2437 - 2446
Factors influencing patient satisfaction after treatments for early-stage non-small cell lung cancer Cecilia PompiliSanjush DalmiaGalina Velikova Original Article – Clinical Oncology Open access 13 September 2021 Pages: 2447 - 2454
Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments Shota OmoriKoji MuramatsuToshiaki Takahashi Original Article – Clinical Oncology 17 September 2021 Pages: 2455 - 2463
Comparing strategy of immune checkpoint inhibitors plus chemotherapy with chemotherapy alone for small cell lung cancer: a meta-analysis based on six RCTs incorporating 2800 participants Yaqi ZhongQing WuXianhe Xie Original Article – Clinical Oncology 17 September 2021 Pages: 2465 - 2474
A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study Xin TangYuan LiZhi-gang Yang Original Article – Clinical Oncology 18 September 2021 Pages: 2475 - 2486
Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial Osman ÖcalDaniel RösslerMax Seidensticker Original Article – Clinical Oncology Open access 20 September 2021 Pages: 2487 - 2496
Non-melanoma skin cancer diagnosis: a comparison between dermoscopic and smartphone images by unified visual and sonification deep learning algorithms A. DascaluB. N. WalkerE. O. David Original Article – Clinical Oncology Open access 21 September 2021 Pages: 2497 - 2505
Impact of preoperative chemotherapy on pathologic nodal status in muscle-invasive bladder cancer: optimal lymphadenectomy in the preoperative chemotherapy era Wonchul LeeWook NamBumsik Hong Original Article – Clinical Oncology 23 September 2021 Pages: 2507 - 2515
Clinical study of MAP2K1-mutated Langerhans cell histiocytosis in children Ying YangChanjuan WangTianyou Wang Original Article – Clinical Oncology 30 September 2021 Pages: 2517 - 2527
Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients Sofia VerkhovskaiaFrancesca Romana Di PietroCristina Fortes Original Article – Clinical Oncology 30 September 2021 Pages: 2529 - 2538
Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy Regina MühleckSebastian SchollUlf Schnetzke Original Article – Clinical Oncology Open access 05 October 2021 Pages: 2539 - 2548
Effect of mindfulness yoga on anxiety and depression in early breast cancer patients received adjuvant chemotherapy: a randomized clinical trial Weimin LiuJuan LiuJing Chen Research Open access 05 July 2022 Pages: 2549 - 2560
Complete and durable response to crizotinib in a patient with malignant pleural mesothelioma harboring CD74-ROS1 fusion Xuehua XieMengxing YouWeiming Huang Letter to the Editors Open access 01 June 2022 Pages: 2561 - 2566
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al Ozan Cem GulerCem Onal Letter to the Editors 13 June 2022 Pages: 2567 - 2568